The Exosomes and Liquid Biopsies Europe 2018 Conference brings together academic researchers, industry researchers, as well as biotechnology and pharmaceutical companies to explore the expanding and evolving field whereby circulating biomarkers of various classes are being evaluated for their potential to be developed into minimally-invasive diagnostics and liquid biopsies for cancer as well as other disease classes.
This Exosomes and Liquid Biopsies 2018 Conference focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), protein-based circulating biomarkers, and exosomes/extracellular vesicles (EVs). There is much interest in the potential of ctDNA and EVs for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this conference bring together the most up-to-date information and current state-of-the-field.
The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early patient monitoring.
Another component of this conference is the exploration of the science behind Exosomes and Extracellular Vesicles - Diagnostic and Therapeutic Potential.
The conference is being held in Rotterdam, The Netherlands-an excellent venue for networking with connections across The Netherlands, Europe and Worldwide. The conference includes an exhibition bringing together companies from around the world focused on developing technologies, tools, products and services serving the liquid biopsy field.
The Conference Chairman and Chief Scientific Advisor is Professor Dominique de Kleijn, Professor, University Medical Center Utrecht, The Netherlands.
*Please note: events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged.
- Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
- Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies
- Emerging Technologies and Emerging Companies Showcase
- Exosomes and Extracellular Vesicles (EVs): Potential for Development of Liquid Biopsies
- Exosomes as Delivery Vehicles and Therapeutic Applications of Exosomes
- Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
- Extracellular Vesicles (EV) in Cancer, Cardiovascular Disease, Neurological Diseases and Beyond
- Grants and Awards across the EU for Exosomes and Liquid Biopsy Research
- Regulatory Landscape for Liquid Biopsies (EU, US and Asia/Pacific)
Dominique PV de Kleijn
Professor, University Medical Center Utrecht
A. Bruce Montgomery Professor of Chemistry, University of Washington
Professor of Cancer Biology, Thomas Jefferson University
Chair Medical CellBiophysics, MIRA Research Institute for Biomedical Technology and Technical Medicine, University of Twente
Assistant Professor, Karolinska Institutet
Professor, The Scripps Research Institute
Professor of Microbiology, Biochemistry & Molecular Genetics, New Jersey Medical School Rutgers University
Associate Director, Discovery Biology, AstraZeneca
Professor, University of Torino
Director of the Laboratory of Rare Human Circulating Tumor Cells, University Medical Centre of Montpellier
Associate Professor and Chair, Oncology Research, Mayo Clinic
Chief, National Cancer Center Research Institute Japan
Director of Research, Institut de Recherche en Cancérologie de Montpellier-INSERM
Associate Professor, Institute of Health and Biomedical Innovation, Queensland University of Technology
Director, University Of Hamburg
Sai Kiang Lim
Research Director, Institute of Medical Biology, A*STAR
Confirmed Speakers to Date
Professor Emeritus, University of Bordeaux
Neurosurgeon, University Medical Center Utrecht and Massachusetts General Hospital/Harvard Medical School
Head of the Translational Laboratory of Rare Circulating Cells, INSERM Gustave Roussy Institute
Researcher, University of Michigan
Scientific Director, Surgical Center for Translational Oncology, University of Lübeck and University Hospital Schleswig-Holstein
Leader of the Microvesicle Research Group, Department for Cardiology, Pulmology and Angiology, University Hospital Bonn
R&D Director, The Cell Factory bvba
PI and Head of Laboratory of Experimental Clinical Chemistry/Vesicle Observation Center, University of Amsterdam
Senior Scientist, Austrian Institute of Technology
Esther Nolte-‘t Hoen
Assistant Professor, Department of Biochemistry & Cell Biology, Faculty of Veterinary Medicine, Utrecht University
Professor, University of Paris Descartes
Professor, Ghent University and CSO, Biogazelle
Weena 686, 3012 CN
Set on the first 15 floors of a modern glass-and-steel high-rise, this posh hotel lies opposite Rotterdam Centraal Station, 1.6 km from the Cube houses and 2.1 km from Diergaarde Blijdorp zoo.
The sophisticated rooms and suites offer free Wi-Fi, flat-screen TVs, minibars, and tea and coffeemakers, plus marble bathrooms with showers and tubs. Upgraded rooms add skyline views, espresso machines and/or access to a private lounge, while suites feature living areas and include breakfast. Room service is available 24/7.
There's a stylish brasserie, a chic cocktail lounge and a lobby cafe. Other amenities include 8 meeting rooms and a 24-hour gym.